Drug
Lae102 Administration
Lae102 Administration: highest development phase Phase 1, developed by Laekna Limited. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Laekna Limited
Trials
| Drug | Phase | Indication |
|---|---|---|
| LAE102 intravenous administration NCT06493084 | Phase 1 | Overweight and Obese Volunteers |
Latest
No recent events.
Follow Lae102 Administration on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.